Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
Condition(s):SchizophreniaLast Updated:July 28, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:July 28, 2023Not yet recruiting
Condition(s):SchizophreniaLast Updated:March 8, 2024Not yet recruiting
Condition(s):Panic DisorderLast Updated:June 27, 2017Unknown status
Condition(s):DepressionLast Updated:June 4, 2010Unknown status
Condition(s):Major Depressive DisorderLast Updated:November 1, 2022Completed
Condition(s):Depressive Disorder, MajorLast Updated:August 31, 2016Suspended
Condition(s):Major Depressive Disorder; Anxiety Disorder; Obsessive Compulsive Disorder; Post-Traumatic Stress DisorderLast Updated:September 25, 2018Terminated
Condition(s):Stroke; Depression; Stroke SequelaeLast Updated:May 20, 2019Completed
Condition(s):Major DepressionLast Updated:May 24, 2018Unknown status
Condition(s):Mild to Moderate Depression.Last Updated:September 19, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.